Cardiac innervation and sudden cardiac death

Masaki Ieda, Keiichi Fukuda

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The heart is extensively innervated and its performance is tightly controlled by the nervous system. Cardiac innervation density varies in diseased hearts leading to unbalanced neural activation and lethal arrhythmia. Diabetic sensory neuropathy causes silent myocardial ischemia, characterized by loss of pain perception during myocardial ischemia, which is a major cause of sudden cardiac death in diabetes mellitus (DM). Despite its clinical importance, the mechanisms underlying the control and regulation of cardiac innervation remain poorly understood. We found that cardiac innervation is determined by the balance between neural chemoattractants and chemorepellents within the heart. Nerve growth factor (NGF), a potent chemoattractant, is induced by endothelin-1 upregulation during development and is highly expressed in cardiomyocytes. By comparison, Sema3a, a neural chemorepellent, is highly expressed in the subendocardium of early stage embryos, and is suppressed during development. The balance of expression between NGF and Seme3a leads to epicardial-to-endocardial transmural sympathetic innervation patterning. We also found that downregulation of cardiac NGF leads to diabetic neuropathy, and that NGF supplementation rescues silent myocardial ischemia in DM. Cardiac innervation patterning is disrupted in Sema3a-deficient and Sema3aoverexpressing mice, leading to sudden death or lethal arrhythmias. The present review focuses on the regulatory mechanisms underlying cardiac innervation and the critical role of these processes in cardiac performance.

Original languageEnglish
Pages (from-to)289-295
Number of pages7
JournalCurrent Cardiology Reviews
Volume5
Issue number4
DOIs
Publication statusPublished - 2009 Nov

Fingerprint

Sudden Cardiac Death
Nerve Growth Factor
Semaphorin-3A
Myocardial Ischemia
Diabetic Neuropathies
Chemotactic Factors
Cardiac Arrhythmias
Diabetes Mellitus
Pain Perception
Endothelin-1
Sudden Death
Cardiac Myocytes
Nervous System
Heart Diseases
Up-Regulation
Down-Regulation
Embryonic Structures

Keywords

  • Arrhythmia
  • Cardiac nerve
  • Nerve growth factor
  • Sema3a
  • Silent myocardial ischemia
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac innervation and sudden cardiac death. / Ieda, Masaki; Fukuda, Keiichi.

In: Current Cardiology Reviews, Vol. 5, No. 4, 11.2009, p. 289-295.

Research output: Contribution to journalArticle

@article{a80c2a8b45c5463d8ada6fbc601be2e2,
title = "Cardiac innervation and sudden cardiac death",
abstract = "The heart is extensively innervated and its performance is tightly controlled by the nervous system. Cardiac innervation density varies in diseased hearts leading to unbalanced neural activation and lethal arrhythmia. Diabetic sensory neuropathy causes silent myocardial ischemia, characterized by loss of pain perception during myocardial ischemia, which is a major cause of sudden cardiac death in diabetes mellitus (DM). Despite its clinical importance, the mechanisms underlying the control and regulation of cardiac innervation remain poorly understood. We found that cardiac innervation is determined by the balance between neural chemoattractants and chemorepellents within the heart. Nerve growth factor (NGF), a potent chemoattractant, is induced by endothelin-1 upregulation during development and is highly expressed in cardiomyocytes. By comparison, Sema3a, a neural chemorepellent, is highly expressed in the subendocardium of early stage embryos, and is suppressed during development. The balance of expression between NGF and Seme3a leads to epicardial-to-endocardial transmural sympathetic innervation patterning. We also found that downregulation of cardiac NGF leads to diabetic neuropathy, and that NGF supplementation rescues silent myocardial ischemia in DM. Cardiac innervation patterning is disrupted in Sema3a-deficient and Sema3aoverexpressing mice, leading to sudden death or lethal arrhythmias. The present review focuses on the regulatory mechanisms underlying cardiac innervation and the critical role of these processes in cardiac performance.",
keywords = "Arrhythmia, Cardiac nerve, Nerve growth factor, Sema3a, Silent myocardial ischemia, Sudden cardiac death",
author = "Masaki Ieda and Keiichi Fukuda",
year = "2009",
month = "11",
doi = "10.2174/157340309789317904",
language = "English",
volume = "5",
pages = "289--295",
journal = "Current Cardiology Reviews",
issn = "1573-403X",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Cardiac innervation and sudden cardiac death

AU - Ieda, Masaki

AU - Fukuda, Keiichi

PY - 2009/11

Y1 - 2009/11

N2 - The heart is extensively innervated and its performance is tightly controlled by the nervous system. Cardiac innervation density varies in diseased hearts leading to unbalanced neural activation and lethal arrhythmia. Diabetic sensory neuropathy causes silent myocardial ischemia, characterized by loss of pain perception during myocardial ischemia, which is a major cause of sudden cardiac death in diabetes mellitus (DM). Despite its clinical importance, the mechanisms underlying the control and regulation of cardiac innervation remain poorly understood. We found that cardiac innervation is determined by the balance between neural chemoattractants and chemorepellents within the heart. Nerve growth factor (NGF), a potent chemoattractant, is induced by endothelin-1 upregulation during development and is highly expressed in cardiomyocytes. By comparison, Sema3a, a neural chemorepellent, is highly expressed in the subendocardium of early stage embryos, and is suppressed during development. The balance of expression between NGF and Seme3a leads to epicardial-to-endocardial transmural sympathetic innervation patterning. We also found that downregulation of cardiac NGF leads to diabetic neuropathy, and that NGF supplementation rescues silent myocardial ischemia in DM. Cardiac innervation patterning is disrupted in Sema3a-deficient and Sema3aoverexpressing mice, leading to sudden death or lethal arrhythmias. The present review focuses on the regulatory mechanisms underlying cardiac innervation and the critical role of these processes in cardiac performance.

AB - The heart is extensively innervated and its performance is tightly controlled by the nervous system. Cardiac innervation density varies in diseased hearts leading to unbalanced neural activation and lethal arrhythmia. Diabetic sensory neuropathy causes silent myocardial ischemia, characterized by loss of pain perception during myocardial ischemia, which is a major cause of sudden cardiac death in diabetes mellitus (DM). Despite its clinical importance, the mechanisms underlying the control and regulation of cardiac innervation remain poorly understood. We found that cardiac innervation is determined by the balance between neural chemoattractants and chemorepellents within the heart. Nerve growth factor (NGF), a potent chemoattractant, is induced by endothelin-1 upregulation during development and is highly expressed in cardiomyocytes. By comparison, Sema3a, a neural chemorepellent, is highly expressed in the subendocardium of early stage embryos, and is suppressed during development. The balance of expression between NGF and Seme3a leads to epicardial-to-endocardial transmural sympathetic innervation patterning. We also found that downregulation of cardiac NGF leads to diabetic neuropathy, and that NGF supplementation rescues silent myocardial ischemia in DM. Cardiac innervation patterning is disrupted in Sema3a-deficient and Sema3aoverexpressing mice, leading to sudden death or lethal arrhythmias. The present review focuses on the regulatory mechanisms underlying cardiac innervation and the critical role of these processes in cardiac performance.

KW - Arrhythmia

KW - Cardiac nerve

KW - Nerve growth factor

KW - Sema3a

KW - Silent myocardial ischemia

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=70449567764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449567764&partnerID=8YFLogxK

U2 - 10.2174/157340309789317904

DO - 10.2174/157340309789317904

M3 - Article

VL - 5

SP - 289

EP - 295

JO - Current Cardiology Reviews

JF - Current Cardiology Reviews

SN - 1573-403X

IS - 4

ER -